Middle East respiratory syndrome coronavirus: five years later

References

• Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820.
   PubMed Web of Science ®Google Scholar
• Middle East respiratory syndrome coronavirus (MERS-CoV) [Internet]. Geneva: World Health Organization (WHO); 2017. Mar 27. [cited 2017 May 25]. Available from: http://www.who.int/emergencies/mers-cov/en/
   Google Scholar
• Nishiura H, Endo A, Saitoh M, et al. Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open. 2016;6(2):e009936.
   PubMed Web of Science ®Google Scholar
• Nishiura H, Miyamatsu Y, Mizumoto K. Objective determination of end of MERS outbreak, South Korea, 2015. Emerg Infect Dis. 2016;22(1):146.
   PubMed Web of Science ®Google Scholar
• Park HY, Lee EJ, Ryu YA, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015;20(25):21169.
   PubMedGoogle Scholar
• De Groot RJ, Baker SC, Baric R, et al. Family coronaviridae. In: King AMQ, Adams MJ, Carstens EB, et al., editors. Virus taxonomy: classification and nomenclature of viruses. Ninth report of the International Committee on Taxonomy of Viruses. London (UK): Academic Press; 2012. p. 806–820.
   Google Scholar
• Drexler JF, Corman VM, Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res. 2014;101:45–56.
   PubMed Web of Science ®Google Scholar
• Middle East respiratory syndrome coronavirus (MERS-CoV) Fact sheet. [Internet]. Geneva: World Health Organization (WHO); 2017. May. [cited 2017 May 25]. Available from: http://www.who.int/mediacentre/factsheets/mers-cov/en/#
   Google Scholar
• Corman VM, Ithete NL, Richards LR, et al. Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol. 2014;88(19):11297–11303.
   PubMed Web of Science ®Google Scholar
• Ithete NL, Stoffberg S, Corman VM, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013;19(10):1697–1699.
   PubMed Web of Science ®Google Scholar
• Corman VM, Kallies R, Philipps H, et al. Characterization of a novel betacoronavirus related to Middle East respiratory syndrome coronavirus in European hedgehogs. J Virol. 2014;88(1):717–724.
   PubMed Web of Science ®Google Scholar
• Oh MD, Park WB, Choe PG, et al. Viral load kinetics of MERS coronavirus infection. NEJM. 2016;375(13):1303–1305.
   PubMed Web of Science ®Google Scholar
• Corman VM, Albarrak AM, Omrani AS, et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis. 2015;62(4):477–483.
   PubMed Web of Science ®Google Scholar
• Cotten M, Watson SJ, Kellam P, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet. 2013;382(9909):1993–2002.
   PubMed Web of Science ®Google Scholar
• Cotten M, Watson SJ, Zumla AI, et al. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio. 2014;5(1):e01062–13.
   PubMed Web of Science ®Google Scholar
• Kim JY, Song JY, Yoon YK, et al. Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother. 2015;47(4):278–302.
   PubMedGoogle Scholar
• Müller MA, Raj VS, Muth D, et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio. 2012;3(6):e00515–12.
   PubMed Web of Science ®Google Scholar
• Chan RW, Hemida MG, Kayali G, et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2(10):813–822.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chu H, Li C, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis. 2014;209(9):1331–1342.
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761.
   PubMed Web of Science ®Google Scholar
• Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016;6:25359.
   PubMed Web of Science ®Google Scholar
• Oboho IK, Tomczyk SM, Al-Asmari AM, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. NEJM. 2015;372(9):846–854.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Zumla AI, Al-Hakeem RF, et al. Family cluster of Middle East respiratory syndrome coronavirus infections. NEJM. 2013;368(26):2487–2494.
   PubMed Web of Science ®Google Scholar
• Almekhlafi GA, Albarrak MM, Mandourah Y, et al. Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients. Crit Care. 2016;20(1):1.
   PubMed Web of Science ®Google Scholar
• Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shen L, Gu X. Evolutionary dynamics of MERS-CoV: potential recombination, positive selection and transmission. Sci Rep. 2016;6:25049.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq J, Memish ZA. An update on Middle East respiratory syndrome: 2 years later. Expert Rev Respir Med. 2015;9(3):327–335. .
   PubMed Web of Science ®Google Scholar
• Middle East respiratory syndrome coronavirus (MERS-CoV) – Republic of Korea. Disease outbreak news. [Internet]. Geneva: World Health Organization (WHO); 2015 Oct. [cited 2017 May 25]. Available from: http://www.who.int/csr/don/25-october-2015-mers-korea/en/
   Google Scholar
• Wang Y, Liu D, Shi W, et al. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis. MBio. 2015;6(5):e01280–15.
   PubMed Web of Science ®Google Scholar
• Hui DS, Perlman S, Zumla A. Spread of MERS to South Korea and China. Lancet Respir Med. 2015;3(7):509–510.
   PubMed Web of Science ®Google Scholar
• Coronavirus infections. Disease outbreak news [Internet]. Geneva: World Health Organization (WHO); 2017 Jul 6. [cited 2017 Jul 24]. Available from: http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/
   Google Scholar
• Balkhy HH, Alenazi TH, Alshamrani MM, et al. Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital—Riyadh, Saudi Arabia, 2015. MMWR. 2016;65:163-164.
   Web of Science ®Google Scholar
• Chen X, Chughtai AA, Dyda A, et al. Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. Emerg Microbes Infect. 2017;6(6):e51.
   PubMed Web of Science ®Google Scholar
• Butt TS, Koutlakis-Barron I, AlJumaah S, et al. Infection control and prevention practices implemented to reduce transmission risk of Middle East respiratory syndrome-coronavirus in a tertiary care institution in Saudi Arabia. Am J Infect Control. 2016;44(5):605–611.
   PubMed Web of Science ®Google Scholar
• Hastings DL, Tokars JI, Abdel Aziz IZ, et al. Outbreak of Middle East respiratory syndrome at tertiary care hospital, Jeddah, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22(5):794–801.
   PubMed Web of Science ®Google Scholar
• Balkhy HH, Perl TM, Arabi YM. Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): our achilles heel. J Infect Public Health. 2016;9(3):208-212. pii: S1876-0341(16)30023-5.
   Web of Science ®Google Scholar
• Hunter JC, Nguyen D, Aden B, et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis. 2016;22(4):647.
   PubMed Web of Science ®Google Scholar
• Scientific Advisory Board, Ministry of Health, Kingdom of Saudi Arabia. Infection prevention and control guidelines for the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. 4th ed. Riyadh (KSA): Ministry of Health, Kingdom of Saudi Arabia. 2017.
   Google Scholar
• Al-Hameed F, Wahla AS, Siddiqui S, et al. Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia. J Intensive Care Med. 2016;31(5):344–348.
   PubMed Web of Science ®Google Scholar
• Alraddadi B, Bawareth N, Omar H, et al. Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital. Ann Thorac Med. 2016;11(2):128.
   PubMed Web of Science ®Google Scholar
• Gossner C, Danielson N, Gervelmeyer A, et al. Human-dromedary camel interactions and the risk of acquiring zoonotic middle east respiratory syndrome coronavirus infection. Zoonoses Public Health. 2016;63(1):1–9.
   PubMed Web of Science ®Google Scholar
• Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22(1):49–55.
   PubMed Web of Science ®Google Scholar
• Reusken CB, Farag EA, Haagmans BL, et al. Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013–2014. Emerg Infect Dis. 2015;21(8):1422.
   PubMed Web of Science ®Google Scholar
• Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. NEJM. 2014;370(26):2499–2505.
   PubMed Web of Science ®Google Scholar
• Ali M, El-Shesheny R, Kandeil A, et al. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill. 2017;22(11).
   PubMedGoogle Scholar
• Chu DK, Oladipo JO, Perera R, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill. 2015;20(49). DOI:10.2807/1560-7917.ES.2015.20.49.30086
   PubMedGoogle Scholar
• Reusken CB, Messadi L, Feyisa A, et al. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014;20(8):1370–1374.
   PubMed Web of Science ®Google Scholar
• Farag EABA, Reusken CBEM, Haagmans BL, et al. High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol. 2015;5:28305.
   PubMedGoogle Scholar
• Müller MA, Meyer B, Corman VM, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15(5):559–564.
   PubMed Web of Science ®Google Scholar
• Saqib M, Sieberg A, Hussain MH, et al. Serologic evidence for MERS-CoV infection in dromedary camels, Punjab, Pakistan, 2012–2015. Emerg Infect Dis. 2017;23(3):550.
   PubMed Web of Science ®Google Scholar
• Liljander A, Meyer B, Jores J, et al. MERS-CoV Antibodies in Humans, Africa, 2013–2014. Emerg Infect Dis. 2016;22(6):1086.
   PubMed Web of Science ®Google Scholar
• Reusken CB, Chrispijn Schilp V, De Bruin E, et al. MERS-CoV infection of alpaca in a region where MERS-CoV is endemic. Emerg Infect Dis. 2016;22(6):1129.
   PubMed Web of Science ®Google Scholar
• Funk AL, Goutard FL, Miguel E, et al. MERS-CoV at the animal-human interface: inputs on exposure pathways from an expert-opinion elicitation. Front Vet Sci. 2016;3:88.
   PubMedGoogle Scholar
• Moon S, Son JS. Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis. 2017;64(10):1457–1458.
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251–254.
   PubMed Web of Science ®Google Scholar
• Wang N, Shi X, Jiang L, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013;23(8):986–993.
   PubMed Web of Science ®Google Scholar
• Durai P, Batool M, Shah M, et al. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med. 2015;47(8):e181.
   PubMed Web of Science ®Google Scholar
• Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013;87(23):12552–12561.
   PubMed Web of Science ®Google Scholar
• Qian Z, Dominguez SR, Holmes KV. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One. 2013;8(10):e76469.
   PubMed Web of Science ®Google Scholar
• Millet JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. PNAS. 2014;111(42):15214–15219.
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu C, Du L, et al. Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus. J Virol. 2015;89(17):9119–9123.
   PubMed Web of Science ®Google Scholar
• Kim Y, Cheon S, Min CK, et al. Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. mBio. 2016;7(2):e00019–16.
   PubMed Web of Science ®Google Scholar
• Modjarrad K. MERS-CoV vaccine candidates in development: the current landscape. Vaccine. 2016;34(26):2982–2987.
   PubMed Web of Science ®Google Scholar
• Park D, Huh HJ, Kim YJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud. 2016 11;2(6):1.
   Google Scholar
• Xie Q, Cao Y, Su J, et al. Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms. Arch Virol. 2017 Apr 18;162:2445–2449.
   PubMed Web of Science ®Google Scholar
• Forni D, Filippi G, Cagliani R, et al. The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses. Sci Rep. 2015;5:14480.
   PubMed Web of Science ®Google Scholar
• Baseler L, De Wit E, Feldmann H. A comparative review of animal models of Middle East respiratory syndrome coronavirus infection. Vet Pathol. 2016;53(3):521–531.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Miazgowicz KL, Milne-Price S, et al. Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol. 2014;88(16):9220–9232.
   PubMed Web of Science ®Google Scholar
• Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015;23(8):468–478.
   PubMed Web of Science ®Google Scholar
• Peck KM, Burch CL, Heise MT, et al. Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives. Ann Rev Virol. 2015 11;2(1):95–117.
   PubMed Web of Science ®Google Scholar
• Peck KM, Cockrell AS, Yount BL, et al. Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection. J Virol. 2015;89(8):4696–4699.
   PubMed Web of Science ®Google Scholar
• Li K, Wohlford-Lenane C, Channappanavar R, et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017;114(15):E3119–E3128.
   PubMed Web of Science ®Google Scholar
• Treatment of MERS-CoV; information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients. [Internet]. Oxford (UK): Public Health England/ISARIC; 2015. Sep. [cited 2017 May 25]. Available from: https://www.google.ie/?gws_rd=ssl#q=public+health+england+treatment+mers-cov
   Google Scholar
• Al-Tawfiq J, Memish ZA. Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV). Expert Rev Anti Infect Ther. 2017;15(3):269–275.
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan JFW, Azhar EI, et al. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327–347.
   PubMed Web of Science ®Google Scholar
• Perlman S, Vijay R. Middle East respiratory syndrome vaccines. Int J Infect Dis. 2016;47:23–28.
   PubMed Web of Science ®Google Scholar
• Singh SK. Middle East respiratory syndrome virus pathogenesis. Semin Respir Crit Care Med. 2016;37(4):572–577.
   PubMed Web of Science ®Google Scholar
• Kim UJ, Won E, Kee S, et al. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455–459.
   PubMed Web of Science ®Google Scholar
• Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211(1):80–90.
   PubMed Web of Science ®Google Scholar
• Hung IFN, To KKW, Lee C, et al. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest. 2013;144(2):464–473.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Al-Enezi F, Longuere K, et al. Feasibility of a randomized controlled trial to assess treatment of Middle East respiratory syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians. BMC Anesthesiol. 2016;16(1):36.
   PubMed Web of Science ®Google Scholar
• Arabi Y, Balkhy H, Hajeer, et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. SpringerPlus. 2015;4:709.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389–397.
   PubMed Web of Science ®Google Scholar
• Kapoor M, Pringle K, Kumar A, et al. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis. 2014;59(11):1511–1518.
   PubMed Web of Science ®Google Scholar
• Du L, Yang Y, Zhou Y, et al. MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21(2):131–143.
   PubMed Web of Science ®Google Scholar
• Ying T, Du L, Ju TW, et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 2014;88(14):7796–7805.
   PubMed Web of Science ®Google Scholar
• Agrawal AS, Ying T, Tao X, et al. Passive transfer of A germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection. Sci Rep. 2016;6:31629.
   PubMed Web of Science ®Google Scholar
• Houser KV, Gretebeck L, Ying T, et al. Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection. J Infect Dis. 2016;213(10):1557–1561.
   PubMed Web of Science ®Google Scholar
• Jiang L, Wang N, Zuo T, et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med. 2014;6(234):234ra59.
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang S, Jiang L, et al. Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27. Sci Rep. 2015;5:13133.
   PubMed Web of Science ®Google Scholar
• Li Y, Wan Y, Liu P, et al. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015;25(11):1237–1249.
   PubMed Web of Science ®Google Scholar
• Qiu H, Sun S, Xiao H, et al. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection. Antiviral Res. 2016;132:141–148.
   PubMed Web of Science ®Google Scholar
• Corti D, Passini N, Lanzavecchia A, et al. Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome. J Infect Public Health. 2016;9(3):231–235.
   PubMed Web of Science ®Google Scholar
• Johnson RF, Bagci U, Keith L, et al. 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology. 2016;490:49–58.
   PubMed Web of Science ®Google Scholar
• Wang L, Shi W, Joyce MG, et al. Evaluation of candidate vaccine approaches for MERS-CoV. ‎Nat Commun. 2015;6:7712.
   PubMed Web of Science ®Google Scholar
• Pascal KE, Coleman CM, Mujica AO, et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2015;112(28):8738–8743.
   PubMed Web of Science ®Google Scholar
• Excler J, Delvecchio CJ, Wiley RE, et al. Toward developing a preventive MERS-CoV vaccine-report from a workshop organized by the Saudi Arabia ministry of health and the international vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015. Emerg Infect Dis. 2016;22(8):e1–e7.
   PubMed Web of Science ®Google Scholar
• Volz A, Kupke A, Song F, et al. Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein. J Virol. 2015;89(16):8651–8656.
   PubMed Web of Science ®Google Scholar
• Guo X, Deng Y, Chen H, et al. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector‐based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015;145(4):476–484.
   PubMed Web of Science ®Google Scholar
• Malczyk AH, Kupke A, Prüfer S, et al. A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J Virol. 2015;89(22):11654–11667.
   PubMed Web of Science ®Google Scholar
• Haagmans BL, van den Brand JMA, Raj VS, et al. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science. 2016;351(6268):77–81.
   PubMed Web of Science ®Google Scholar
• Wirblich C, Coleman CM, Kurup D, et al. One-health: a safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus. J Virol. 2017;91(2).
   PubMed Web of Science ®Google Scholar
• GLS-5300 SynCon® immunotherapy targeting Middle East Respiratory Syndrome. [Internet]. Plymouth Meeting (PA): Inovio Pharmaceuticals, Inc.; 2016. [cited 2017 25]. Available from: http://www.inovio.com/products/infectious-disease-vaccines/mers/
   Google Scholar
• Muthumani K, Falzarano D, Reuschel EL, et al. A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7(301):301ra132.
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng X, Gai W, et al. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antiviral Res. 2017;140:55–61.
   PubMed Web of Science ®Google Scholar
• WHO target product profiles for MERS-CoV vaccines [Internet]. Geneva: World Health Organization; May 2017. [cited 2017 May 25]. Available from: http://www.who.int/emergencies/mers-cov/en/
   Google Scholar
• Hemida MG, Chu DK, Poon LL, et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis. 2014;20(7):1231.
   PubMed Web of Science ®Google Scholar
• Agrawal AS, Tao X, Algaissi A, et al. Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccin Immunother. 2016;12(9):2351–2356.
   PubMed Web of Science ®Google Scholar
• Al-Amri SS, Abbas AT, Siddiq LA, et al. Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein. Sci Rep. 2017;7:44875.
   PubMed Web of Science ®Google Scholar
• Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 2014;5: Article number: 3067.
   Web of Science ®Google Scholar
• Channappanavar R, Lu L, Xia S, et al. Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection. J Infect Dis. 2015;212(12):1894–1903.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Vedantham P, Lu K, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76–84.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Matsuyama S, Li X, et al. Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob Agents Chemother. 2016;60(11):6532–6539.
   PubMed Web of Science ®Google Scholar
• Zhou N, Pan T, Zhang J, et al. Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola Virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV). J Biol Chem. 2016;291(17):9218–9232.
   PubMed Web of Science ®Google Scholar
• Cheng K, Cheng S, Chen W, et al. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res. 2015;115:9–16.
   PubMed Web of Science ®Google Scholar
• Lee H, Lei H, Santarsiero BD, et al. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV. ACS Chem Biol. 2015;10(6):1456–1465.
   PubMed Web of Science ®Google Scholar
• Clasman JR, Báez-Santos YM, Mettelman RC, et al. X-ray structure and enzymatic activity profile of a core papain-like protease of MERS coronavirus with utility for structure-based drug design. Sci Rep. 2017;7:40292.
   PubMed Web of Science ®Google Scholar
• Phillips JM, Gallagher T, Weiss SR. Neurovirulent murine coronavirus JHM.SD uses cellular zinc metalloproteases for virus entry and cell-cell fusion. J Virol. 2017;91(8).
   Web of Science ®Google Scholar
• Dyall J, Coleman CM, Hart BJ, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014;58(8):4885–4893.
   PubMed Web of Science ®Google Scholar
• Coleman CM, Sisk JM, Mingo RM, et al. Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. J Virol. 2016;90(19):8924–8933.
   PubMed Web of Science ®Google Scholar
• Chan C, Chu H, Wang Y, et al. Carcinoembryonic antigen-related cell adhesion molecule 5 is an important surface attachment factor that facilitates entry of Middle East respiratory syndrome coronavirus. J Virol. 2016;90(20):9114–9127.
   PubMed Web of Science ®Google Scholar
• Hayden FG, Farrar J, Peiris JSM. Towards improving clinical management of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2014;14(7):544–546.
   PubMed Web of Science ®Google Scholar